🚀 VC round data is live in beta, check it out!
Sonova Valuation Multiples
Discover revenue and EBITDA valuation multiples for Sonova and similar public comparables like Smith & Nephew, Medpace, Globus Medical, Insulet and more.
Sonova Overview
About Sonova
Sonova is one of the world's largest manufacturers and distributors of hearing aids. The company is based in Switzerland and distributes its products in more than 100 countries through its internal sales team and independent retailers. It also sells cochlear implants and audio technologies.
Founded
1947
HQ
Employees
18.0K
Website
Financials (LTM)
EV
$14B
Sonova Financials
Sonova reported last 12-month revenue of $5B and EBITDA of $1B.
In the same LTM period, Sonova generated $3B in gross profit, $1B in EBITDA, and $700M in net income.
Revenue (LTM)
Sonova P&L
In the most recent fiscal year, Sonova reported revenue of $5B and EBITDA of $1B.
Sonova expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $5B | XXX | $5B | XXX | XXX | XXX |
| Gross Profit | $3B | XXX | $4B | XXX | XXX | XXX |
| Gross Margin | 71% | XXX | 72% | XXX | XXX | XXX |
| EBITDA | $1B | XXX | $1B | XXX | XXX | XXX |
| EBITDA Margin | 26% | XXX | 24% | XXX | XXX | XXX |
| EBIT Margin | 20% | XXX | 18% | XXX | XXX | XXX |
| Net Profit | $700M | XXX | $692M | XXX | XXX | XXX |
| Net Margin | 15% | XXX | 14% | XXX | XXX | XXX |
| Net Debt | — | — | $1B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Sonova Stock Performance
Sonova has current market cap of $15B, and enterprise value of $14B.
Market Cap Evolution
Sonova's stock price is $245.10.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $14B | $15B | 0.2% | XXX | XXX | XXX | $11.61 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSonova Valuation Multiples
Sonova trades at 3.0x EV/Revenue multiple, and 11.4x EV/EBITDA.
EV / Revenue (LTM)
Sonova Financial Valuation Multiples
As of April 19, 2026, Sonova has market cap of $15B and EV of $14B.
Equity research analysts estimate Sonova's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Sonova has a P/E ratio of 20.9x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $15B | XXX | $15B | XXX | XXX | XXX |
| EV (current) | $14B | XXX | $14B | XXX | XXX | XXX |
| EV/Revenue | 3.0x | XXX | 2.9x | XXX | XXX | XXX |
| EV/EBITDA | 11.4x | XXX | 12.0x | XXX | XXX | XXX |
| EV/EBIT | 15.1x | XXX | 16.1x | XXX | XXX | XXX |
| EV/Gross Profit | 4.2x | XXX | 4.0x | XXX | XXX | XXX |
| P/E | 20.9x | XXX | 21.1x | XXX | XXX | XXX |
| EV/FCF | 17.6x | XXX | 17.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Sonova Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Sonova Margins & Growth Rates
Sonova's revenue in the last 12 month grew by 4%.
Sonova's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Sonova's rule of 40 is 29% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Sonova's rule of X is 31% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Sonova Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 4% | XXX | (3%) | XXX | XXX | XXX |
| EBITDA Margin | 26% | XXX | 24% | XXX | XXX | XXX |
| EBITDA Growth | 7% | XXX | 5% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 29% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 31% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 37% | XXX | 36% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 10% | XXX | 10% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 6% | XXX | 8% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 54% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Sonova Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Sonova | XXX | XXX | XXX | XXX | XXX | XXX |
| Smith & Nephew | XXX | XXX | XXX | XXX | XXX | XXX |
| Medpace | XXX | XXX | XXX | XXX | XXX | XXX |
| Globus Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Insulet | XXX | XXX | XXX | XXX | XXX | XXX |
| Cooper Companies | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Sonova M&A Activity
Sonova acquired XXX companies to date.
Last acquisition by Sonova was on XXXXXXXX, XXXXX. Sonova acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Sonova
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialSonova Investment Activity
Sonova invested in XXX companies to date.
Sonova made its latest investment on XXXXXXXX, XXXXX. Sonova invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Sonova
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Sonova
| When was Sonova founded? | Sonova was founded in 1947. |
| Where is Sonova headquartered? | Sonova is headquartered in Switzerland. |
| How many employees does Sonova have? | As of today, Sonova has over 18K employees. |
| Is Sonova publicly listed? | Yes, Sonova is a public company listed on SIX Swiss Exchange. |
| What is the stock symbol of Sonova? | Sonova trades under SOON ticker. |
| When did Sonova go public? | Sonova went public in 2009. |
| Who are competitors of Sonova? | Sonova main competitors are Smith & Nephew, Medpace, Globus Medical, Insulet. |
| What is the current market cap of Sonova? | Sonova's current market cap is $15B. |
| What is the current revenue of Sonova? | Sonova's last 12 months revenue is $5B. |
| What is the current revenue growth of Sonova? | Sonova revenue growth (NTM/LTM) is 4%. |
| What is the current EV/Revenue multiple of Sonova? | Current revenue multiple of Sonova is 3.0x. |
| Is Sonova profitable? | Yes, Sonova is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Sonova? | Sonova's last 12 months EBITDA is $1B. |
| What is Sonova's EBITDA margin? | Sonova's last 12 months EBITDA margin is 26%. |
| What is the current EV/EBITDA multiple of Sonova? | Current EBITDA multiple of Sonova is 11.4x. |
| What is the current FCF of Sonova? | Sonova's last 12 months FCF is $810M. |
| What is Sonova's FCF margin? | Sonova's last 12 months FCF margin is 17%. |
| What is the current EV/FCF multiple of Sonova? | Current FCF multiple of Sonova is 17.6x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.